Related Experiment Videos

Changes in health-related quality of life following percutaneous coronary intervention: a longitudinal study

Man Sin Wong1, Sek Ying Chair

  • 1Department of Medicine, Queen Mary Hospital, Pokfulum, Hong Kong.

Insights

Percutaneous coronary intervention (PCI) improved health-related quality of life (HRQoL) in Hong Kong Chinese patients one month post-procedure. However, these benefits diminished by three months, indicating a need for ongoing nursing support.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Coronary artery disease (CAD) significantly impacts mortality and morbidity in developed nations.
  • Percutaneous coronary intervention (PCI) is a common treatment for CAD, necessitating an understanding of its effect on patient well-being.
  • Assessing health-related quality of life (HRQoL) before and after PCI is crucial for effective disease management and patient care.

Purpose of the Study:

  • To evaluate changes in HRQoL among Hong Kong Chinese patients undergoing PCI.
  • To compare HRQoL from the pre-PCI baseline to three months post-PCI.

Main Methods:

  • A longitudinal, one-group observational study design was employed.
  • Data were collected from 78 eligible patients undergoing non-emergency PCI at a regional public hospital in Hong Kong.
  • Health-related quality of life was measured using the SF-36 and Seattle Angina Questionnaire (SAQ) at baseline, 1 month, and 3 months post-PCI.

Main Results:

  • Sixty-five patients completed the study.
  • Significant improvements in most SF-36 and SAQ domains were observed at one month post-PCI.
  • While SF-36 scores generally improved at three months compared to baseline, the SAQ angina stability score decreased, and not all domain improvements were sustained.

Conclusions:

  • PCI offers short-term benefits to patient HRQoL.
  • The positive effects of PCI on HRQoL are not fully sustained at three months.
  • Post-PCI nursing interventions are essential to maintain and enhance long-term HRQoL, requiring immediate implementation after the procedure.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...